cyproheptadine has been researched along with Rhinitis, Allergic, Seasonal in 55 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Rhinitis, Allergic, Seasonal: Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One hundred and seven hay fever patients, sensitive to birch pollen, were randomized into three parallel groups receiving loratadine 40 mg once daily, clemastine 1 mg twice daily, or placebo during the birch pollen season." | 9.06 | Treatment of hay fever with loratadine--a new non-sedating antihistamine. ( Irander, K; Odkvist, LM; Ohlander, B, 1990) |
| "In this double-blind study, 65 patients with hay fever were treated for 14 days with either loratadine 10 mg once daily, astemizole 10 mg once daily, or placebo." | 9.06 | Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. ( Oei, HD, 1988) |
| "The prevalence of allergic rhinitis has exhibited an upward trend, and diabetes is a common endocrine metabolic disorder." | 5.72 | Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes. ( Chen, X; Jiang, P; Liu, Y; Shi, J; Zhang, W, 2022) |
| "To measure the reduction in nasal obstruction using acoustic rhinometry in patients with allergic rhinitis treated with rupatadine." | 5.14 | Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study. ( Bartrá, J; Izquierdo, I; Mullol, J; Muñoz-Cano, R; Picado, C; Serrano, C; Valero, A, 2009) |
| "Subjective single and composite nasal and nonnasal symptoms were consistently less severe with rupatadine use than with placebo use starting from the first evaluation at 15 minutes to the end of the 6-hour Vienna Challenge Chamber challenge, with the most significant effects seen for nasal rhinorrhea, nasal itching, sneezing attacks, and total nasal symptoms (P < ." | 5.12 | Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber. ( Arnáiz, E; Horak, F; Izquierdo, I; Leuratti, C; Pérez, I; Stuebner, P; Zieglmayer, R, 2006) |
| " One hundred and seven hay fever patients, sensitive to birch pollen, were randomized into three parallel groups receiving loratadine 40 mg once daily, clemastine 1 mg twice daily, or placebo during the birch pollen season." | 5.06 | Treatment of hay fever with loratadine--a new non-sedating antihistamine. ( Irander, K; Odkvist, LM; Ohlander, B, 1990) |
| "The efficacy and safety of loratadine, 40 mg once daily, were compared with terfenadine, 60 mg twice daily, and placebo in controlling symptoms of ragweed hay fever." | 5.06 | Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. ( Bedard, P; Del Carpio, J; Gutkowski, A; Hebert, J; Prevost, M; Schulz, J; Turenne, Y; Yeadon, C, 1988) |
| "In this double-blind study, 65 patients with hay fever were treated for 14 days with either loratadine 10 mg once daily, astemizole 10 mg once daily, or placebo." | 5.06 | Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. ( Oei, HD, 1988) |
| " Rupatadine, a molecule with intense antihistaminic activity and with antagonist PAF effects through its interaction with specific receptors, is indicated for the treatment of intermittent or persistent allergic rhinitis and urticaria." | 4.89 | Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. ( Canonica, GW; Compalati, E, 2013) |
| " The rates of adverse events were 6." | 2.90 | Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial. ( Aoki, H; Okubo, K; Suzuki, T; Tanaka, A, 2019) |
| " Incidence of adverse effects was less in the rupatadine group compared with the levocetirizine group." | 2.75 | Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. ( Allala, U; Jaida, J; Maiti, R; Palani, A; Rahman, J, 2010) |
| " All treatments were well tolerated and no serious adverse events were recorded." | 2.71 | A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis. ( Dumur, JP; Izquierdo, I; Pérez, I; Saint-Martin, F, 2004) |
| "Rupatadine is a new second generation H(1)-antihistamine with once-daily dosing that may provide better control of symptoms than the currently used H(1)-receptor blockers because of its dual pharmacological profile (anti-PAF and anti-H(1))." | 2.71 | Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study. ( Castillo, JA; De Molina, M; Guadaño, EM; Meseguer, J; Picado, C; Serra-Batlles, J; Valero, A, 2004) |
| "Terfenadine was more effective than both loratadine (P less than ." | 2.67 | Suppression of epicutaneous reactivity by terfenadine and loratadine. ( Small, P, 1992) |
| "Thus loratadine is an effective and safe antihistamine when given once daily for the symptomatic relief of seasonal allergic rhinitis." | 2.67 | Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis. ( Katelaris, C, 1990) |
| "Pretreatment with azatadine significantly suppressed the number of sneezes following antigen challenge and inhibited the associated elevations in histamine, kinins, and enzyme(s) hydrolyzing the artificial substrate N-alpha-tosyl-L-arginine-methyl-ester in nasal secretions, whereas placebo was inactive." | 2.66 | Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. ( Kagey-Sobotka, A; Lichtenstein, LM; Naclerio, RM; Nimmagadda, I; Norman, PS; Proud, D; Togias, AG; Warner, J, 1986) |
| " Loratadine appears to be a simple, effective and safe therapy for seasonal allergic rhinitis." | 2.66 | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis. ( Andreoli, A; Boner, AL; Marchesi, E; Miglioranzi, P; Richelli, C, 1989) |
| "Loratadine was particularly effective compared with placebo in relieving nasal discharge, sneezing, and itching/burning eyes." | 2.66 | Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. ( Bedard, PM; Del Carpio, J; Gutkowski, A; Hebert, J; Kabbash, L; Nedilski, M; Prevost, M; Schulz, J; Turenne, Y, 1989) |
| " Loratadine was found to be both safe and efficacious." | 2.66 | Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. ( Bergner, A; Connell, JT; Dockhorn, RJ; Falliers, CJ; Grabiec, SV; Shellenberger, MK; Weiler, JM, 1987) |
| "Loratadine was found to be significantly superior to placebo after 3 days of treatment, whereas a significant improvement was only observed after 7 days in patients treated with mequitazine." | 2.66 | Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. ( Bousquet, J; Lherminier, M; Michel, FB; Montes, F; Schwab, D; Skassa-Brociek, W; Verdier, M, 1988) |
| "Two patient groups were treated, one with seasonal allergic rhinitis for two days during the peak of the ragweed season, and another with perennial allergic rhinitis for an extended six-week period." | 2.65 | Controlled comparison of anew antihistamine-decongestant combination to its individual components. ( Falliers, CJ; Redding, MA, 1980) |
| " Eighty percent of patients had symptomatic relief with a twice daily dosage of 2 mg." | 2.65 | Azatadine maleate (Zadine): evaluation in the management of allergic rhinitis. ( Hillas, JL; Somerfield, SD; Wilson, JD, 1981) |
| "Rupatadine is a once-daily non-sedative, selective, long-acting H1 anti-histamine with antagonistic PAF effects through its interaction with specific receptors." | 2.45 | Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. ( Katiyar, S; Prakash, S, 2009) |
| "Rupatadine is a once-daily, non-sedating, selective and long-acting new drug with a strong antagonist activity towards both histamine H(1) receptors and platelet-activating factor receptors." | 2.43 | Rupatadine: pharmacological profile and its use in the treatment of allergic disorders. ( Picado, C, 2006) |
| "Rupatadine is a new agent for the management of diseases with allergic inflammatory conditions, such as seasonal and perennial rhinitis." | 2.42 | Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. ( García-Rafanell, J; Izquierdo, I; Merlos, M, 2003) |
| "In this review of the current treatment of seasonal allergic rhinitis, the clinical studies that compare these four new second-generation H1-receptor antagonists are discussed." | 2.38 | H1-receptor antagonist treatment of seasonal allergic rhinitis. ( Kaiser, HB, 1990) |
| "Loratadine is a long acting antihistamine which has a high selectivity for peripheral histamine H1-receptors and lacks the central nervous system depressant effects often associated with some of the older antihistamines." | 2.38 | Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. ( Clissold, SP; Goa, KL; Sorkin, EM, 1989) |
| "The prevalence of allergic rhinitis has exhibited an upward trend, and diabetes is a common endocrine metabolic disorder." | 1.72 | Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes. ( Chen, X; Jiang, P; Liu, Y; Shi, J; Zhang, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (47.27) | 18.7374 |
| 1990's | 10 (18.18) | 18.2507 |
| 2000's | 10 (18.18) | 29.6817 |
| 2010's | 8 (14.55) | 24.3611 |
| 2020's | 1 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Jiang, P | 1 |
| Chen, X | 1 |
| Zhang, W | 1 |
| Shi, J | 1 |
| Okubo, K | 1 |
| Suzuki, T | 1 |
| Tanaka, A | 1 |
| Aoki, H | 1 |
| Compalati, E | 2 |
| Canonica, GW | 2 |
| Berger, VW | 1 |
| Gudehithlu, SK | 1 |
| Katiyar, S | 1 |
| Prakash, S | 1 |
| LEVIN, L | 1 |
| KELLY, JF | 1 |
| SCHWARTZ, E | 1 |
| Valero, A | 3 |
| Serrano, C | 1 |
| Bartrá, J | 2 |
| Izquierdo, I | 7 |
| Muñoz-Cano, R | 1 |
| Mullol, J | 3 |
| Picado, C | 4 |
| Maiti, R | 1 |
| Rahman, J | 1 |
| Jaida, J | 1 |
| Allala, U | 1 |
| Palani, A | 1 |
| Metz, M | 1 |
| Maurer, M | 2 |
| Giralt, J | 2 |
| del Cuvillo, A | 1 |
| Potter, P | 1 |
| Maspero, JF | 1 |
| Vermeulen, J | 1 |
| Barkai, L | 1 |
| Németh, I | 1 |
| Baillieau, RA | 1 |
| Garde, JM | 1 |
| Doménech, A | 1 |
| Nieto, A | 1 |
| Merlos, M | 1 |
| García-Rafanell, J | 1 |
| JENSEN, K | 1 |
| SMELLIE, H | 1 |
| FRY, L | 1 |
| Saint-Martin, F | 1 |
| Dumur, JP | 1 |
| Pérez, I | 3 |
| Guadaño, EM | 1 |
| Serra-Batlles, J | 1 |
| Meseguer, J | 1 |
| Castillo, JA | 1 |
| De Molina, M | 2 |
| Martínez-Cócera, C | 1 |
| Martí-Guadaño, E | 2 |
| Pola, J | 1 |
| Conde, J | 1 |
| Borja, J | 1 |
| Arnaiz, E | 2 |
| Stuebner, P | 1 |
| Horak, F | 2 |
| Zieglmayer, R | 1 |
| Leuratti, C | 1 |
| Keam, SJ | 1 |
| Plosker, GL | 1 |
| Bousquet, J | 3 |
| Bachert, C | 1 |
| Canonica, WG | 1 |
| Gimenez-Arnau, A | 1 |
| Kowalski, ML | 1 |
| Scadding, G | 1 |
| Van Cauwenberge, P | 1 |
| Tarasido, JC | 1 |
| Zubizaretta, J | 1 |
| Falliers, CJ | 2 |
| Redding, MA | 1 |
| Wilson, JD | 1 |
| Hillas, JL | 1 |
| Somerfield, SD | 1 |
| Naclerio, RM | 2 |
| Connell, JT | 2 |
| Tarnick, M | 1 |
| Kolbas, V | 1 |
| Pansini, K | 1 |
| Small, P | 1 |
| Boner, AL | 2 |
| Richelli, C | 2 |
| Castellani, C | 1 |
| Marchesi, E | 2 |
| Andreoli, A | 2 |
| Frølund, L | 3 |
| Andersson, M | 1 |
| Nolte, H | 1 |
| Baumgarten, C | 1 |
| Pipkorn, U | 1 |
| Kaiser, HB | 1 |
| Massey, WA | 1 |
| Lichtenstein, LM | 2 |
| Katelaris, C | 1 |
| Irander, K | 1 |
| Odkvist, LM | 1 |
| Ohlander, B | 1 |
| Togias, AG | 1 |
| Warner, J | 1 |
| Proud, D | 1 |
| Kagey-Sobotka, A | 1 |
| Nimmagadda, I | 1 |
| Norman, PS | 1 |
| Lebel, B | 1 |
| Chanal, I | 1 |
| Morel, A | 1 |
| Michel, FB | 2 |
| Storms, WW | 1 |
| Bodman, SF | 1 |
| Nathan, RA | 1 |
| Chervinsky, P | 1 |
| Banov, CH | 1 |
| Dockhorn, RJ | 2 |
| Jarmoszuk, I | 1 |
| Zeitz, HJ | 1 |
| McGeady, SJ | 1 |
| Pinnas, JL | 1 |
| Clissold, SP | 1 |
| Sorkin, EM | 1 |
| Goa, KL | 1 |
| Grossman, J | 1 |
| Bronsky, EA | 1 |
| Lanier, BQ | 1 |
| Linzmayer, MI | 1 |
| Moss, BA | 1 |
| Schenkel, EJ | 1 |
| Selner, JC | 1 |
| Miglioranzi, P | 1 |
| Simons, FE | 1 |
| Del Carpio, J | 2 |
| Kabbash, L | 1 |
| Turenne, Y | 2 |
| Prevost, M | 2 |
| Hebert, J | 2 |
| Bedard, PM | 1 |
| Nedilski, M | 1 |
| Gutkowski, A | 2 |
| Schulz, J | 2 |
| Bindslev-Jensen, C | 1 |
| Svendsen, UG | 1 |
| Bruttmann, G | 1 |
| Pedrali, P | 1 |
| Weeke, B | 1 |
| Wolff, HH | 1 |
| Christophers, E | 1 |
| Bedard, P | 1 |
| Yeadon, C | 1 |
| Oei, HD | 1 |
| Bergner, A | 1 |
| Grabiec, SV | 1 |
| Weiler, JM | 1 |
| Shellenberger, MK | 1 |
| Skassa-Brociek, W | 1 |
| Montes, F | 1 |
| Verdier, M | 1 |
| Schwab, D | 1 |
| Lherminier, M | 1 |
| Schultze-Wernighaus, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nasal Ocular Reflexes Contribute to Eye Symptoms in Patients With Allergic Rhinitis[NCT00117832] | 20 participants | Interventional | 2005-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for cyproheptadine and Rhinitis, Allergic, Seasonal
| Article | Year |
|---|---|
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; | 2013 |
Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
Topics: Adolescent; Adult; Cyproheptadine; Histamine H1 Antagonists, Non-Sedating; Humans; Randomized Contro | 2009 |
Rupatadine for the treatment of allergic rhinitis and urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Ac | 2011 |
Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Topics: Animals; Clinical Trials as Topic; Cyproheptadine; Dose-Response Relationship, Drug; Histamine H1 An | 2003 |
Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
Topics: Adolescent; Adult; Animals; Cyproheptadine; Histamine H1 Antagonists; Humans; Psychomotor Performanc | 2006 |
Rupatadine: a review of its use in the management of allergic disorders.
Topics: Adolescent; Adult; Aged; Animals; Anti-Allergic Agents; Cyproheptadine; Drug Interactions; Humans; H | 2007 |
Rupatadine in allergic rhinitis and chronic urticaria.
Topics: Adolescent; Animals; Anti-Allergic Agents; Child; Chronic Disease; Clinical Trials as Topic; Cyprohe | 2008 |
H1-receptor antagonist treatment of seasonal allergic rhinitis.
Topics: Astemizole; Benzhydryl Compounds; Benzimidazoles; Cetirizine; Chlorpheniramine; Clemastine; Cyprohep | 1990 |
The effects of antihistamines beyond H1 antagonism in allergic inflammation.
Topics: Benzhydryl Compounds; Cetirizine; Cyproheptadine; Dermatitis, Atopic; Histamine H1 Antagonists; Hist | 1990 |
Three new non-sedative antihistamines: worth keeping an eye open for.
Topics: Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Rhinitis, All | 1990 |
Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Topics: Animals; Common Cold; Cyproheptadine; Female; Humans; Loratadine; Male; Rhinitis, Allergic, Perennia | 1989 |
35 trials available for cyproheptadine and Rhinitis, Allergic, Seasonal
| Article | Year |
|---|---|
Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Child; Cyproheptadine; Double-Blind Method; Female; Humans; | 2019 |
Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Topics: Administration, Intranasal; Adolescent; Adult; Anti-Allergic Agents; Cyproheptadine; Disease Progres | 2009 |
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Topics: Adolescent; Adult; Cetirizine; Conjunctivitis, Allergic; Cyproheptadine; Eosinophils; Female; Histam | 2010 |
Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Adult; Cyproheptadine; Female; Histamine H1 Ant | 2011 |
Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Analysis of Variance; Anti-Allergic Agents; Argentina; Child; Cyproheptadine; | 2013 |
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Cross-Over Studies; Cyproheptadine; Dose-Respo | 2004 |
Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Allergic Agents; Butyrophenones; Cyproheptadine; Doubl | 2004 |
Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cyproheptadine; Double-Blind Metho | 2005 |
Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Topics: Adolescent; Adult; Antigens, Plant; Cross-Over Studies; Cyproheptadine; Dactylis; Double-Blind Metho | 2006 |
Azatadine maleate/pseudoephedrine sulfate repetabs versus placebo in the treatment of severe seasonal allergic rhinitis.
Topics: Adolescent; Adult; Cyproheptadine; Double-Blind Method; Drug Combinations; Ephedrine; Female; Histam | 1980 |
Azatadine maleate/pseudoephedrine sulfate repetabs versus placebo in the treatment of severe perennial allergic rhinitis.
Topics: Adolescent; Adult; Aged; Cyproheptadine; Delayed-Action Preparations; Double-Blind Method; Drug Comb | 1980 |
Controlled comparison of anew antihistamine-decongestant combination to its individual components.
Topics: Cyproheptadine; Drug Therapy, Combination; Ephedrine; Female; Histamine H1 Antagonists; Humans; Male | 1980 |
Azatadine maleate (Zadine): evaluation in the management of allergic rhinitis.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Cyproheptadine; Double-Blind Method; Female; Hum | 1981 |
The effect of antihistamines on the immediate allergic response: a comparative review.
Topics: Capillary Permeability; Cetirizine; Cyproheptadine; Diphenhydramine; Double-Blind Method; Histamine | 1993 |
Azatadine (optimine)--a new antihistamine.
Topics: Clinical Trials as Topic; Cyproheptadine; Histamine H1 Antagonists; Humans; Placebos; Rhinitis, Alle | 1977 |
A novel method to assess antihistamine and decongestant efficacy.
Topics: Clinical Trials as Topic; Cyproheptadine; Double-Blind Method; Ephedrine; Female; Histamine H1 Antag | 1979 |
Suppression of epicutaneous reactivity by terfenadine and loratadine.
Topics: Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Hypersensitivity; Lor | 1992 |
Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis.
Topics: Adolescent; Astemizole; Child; Conjunctivitis, Allergic; Cyproheptadine; Female; Histamine Antagonis | 1992 |
Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis.
Topics: Administration, Intranasal; Administration, Oral; Adult; Aged; Beclomethasone; Cyproheptadine; Doubl | 1991 |
Suppressive effect of loratadine on allergen-induced histamine release in the nose.
Topics: Adolescent; Adult; Allergens; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists; | 1991 |
The effects of antihistamines beyond H1 antagonism in allergic inflammation.
Topics: Benzhydryl Compounds; Cetirizine; Cyproheptadine; Dermatitis, Atopic; Histamine H1 Antagonists; Hist | 1990 |
Comparative effects of loratadine and azatadine in the treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Aged; Cyproheptadine; Double-Blind Method; Female; Histamine Antagonists; Histami | 1990 |
Treatment of hay fever with loratadine--a new non-sedating antihistamine.
Topics: Clemastine; Cyproheptadine; Double-Blind Method; Drug Evaluation; Female; Histamine Antagonists; Hum | 1990 |
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation.
Topics: Adolescent; Adult; Clinical Trials as Topic; Cyproheptadine; Double-Blind Method; Female; Histamine | 1986 |
Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.
Topics: Adult; Benzhydryl Compounds; Cyproheptadine; Double-Blind Method; Histamine H1 Antagonists; Histamin | 1988 |
SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis.
Topics: Adolescent; Adult; Child; Cyproheptadine; Delayed-Action Preparations; Double-Blind Method; Drug Com | 1989 |
Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis.
Topics: Adolescent; Adult; Aged; Child; Cyproheptadine; Drug Combinations; Ephedrine; Female; Histamine Anta | 1989 |
Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis.
Topics: Administration, Oral; Child; Child, Preschool; Chlorpheniramine; Cyproheptadine; Double-Blind Method | 1989 |
Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Benzhydryl Compounds; Cyproheptadine; Double-Blind Method; Drug Administration Sc | 1989 |
A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Child; Clinical Trials as Topic; Cyproheptadine; Doub | 1988 |
Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Benzhydryl Compounds; Clinical Trials as Topic; Cyproheptadine; Double-Blind Meth | 1988 |
Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
Topics: Adolescent; Adult; Astemizole; Benzimidazoles; Clinical Trials as Topic; Cyproheptadine; Dose-Respon | 1988 |
Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis.
Topics: Capsules; Clemastine; Clinical Trials as Topic; Cyproheptadine; Double-Blind Method; Histamine Antag | 1987 |
Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Topics: Adolescent; Adult; Clinical Trials as Topic; Cyproheptadine; Double-Blind Method; Female; Humans; Lo | 1988 |
[Disodium cromoglycate in comparison with antihistaminics (loratadine) in seasonal allergic rhinitis].
Topics: Adult; Clinical Trials as Topic; Cromolyn Sodium; Cyproheptadine; Histamine Antagonists; Humans; Lor | 1988 |
10 other studies available for cyproheptadine and Rhinitis, Allergic, Seasonal
| Article | Year |
|---|---|
Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes.
Topics: Acupuncture Points; Cyproheptadine; Diabetes Mellitus; Fumarates; Humans; Immunoglobulin E; Rhinitis | 2022 |
Re: Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Letter to the editor.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Rhinitis, Allergic, Perenni | 2013 |
Re Letter to the editor re: Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhinoconjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin 2013 Jul 5.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Rhinitis, Allergic, Perenni | 2014 |
A clinical evaluation of neo-antergan and antistine in the treatment of ragweed hay fever.
Topics: Ambrosia; Antazoline; Cyproheptadine; Histamine Antagonists; Humans; Hyperthermia, Induced; Rhinitis | 1948 |
The effect of antiserotonin (cyproheptadine) and antihistamine on cutaneous allergy.
Topics: Anti-Allergic Agents; Cyproheptadine; Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Rhinitis | 1960 |
Comparison of an antiserotonin (cyproheptadine) and a pure antihistamine chlorpheniramine in hay fever.
Topics: Anti-Allergic Agents; Chlorpheniramine; Cyproheptadine; Histamine H1 Antagonists; Humans; Rhinitis, | 1962 |
[Results of the treatment in cases of cold urticaria, cold pruritus and cold rhinitis with peritol (zyproheptadinhydrochlorid) (author's transl)].
Topics: Cold Temperature; Cyproheptadine; Humans; Pruritus; Rhinitis, Allergic, Seasonal; Urticaria | 1979 |
[Clinical testing of Idulian in hay fever in children].
Topics: Age Factors; Child; Cyproheptadine; Drug Evaluation; Humans; Rhinitis, Allergic, Seasonal | 1975 |
Loratadine, a non-sedating H1-receptor antagonist (antihistamine)
Topics: Cyproheptadine; Histamine Antagonists; Histamine H1 Antagonists; Humans; Loratadine; Rhinitis, Aller | 1989 |
[Congestan].
Topics: Cyproheptadine; Drug Combinations; Ephedrine; Histamine H1 Antagonists; Humans; Pseudoephedrine; Rhi | 1987 |